Q&A With Covington's Mark Lynch

Law360, New York (May 9, 2012, 2:55 PM EDT) -- Mark Lynch is a partner in Covington & Burling LLP's Washington, D.C., office and co-chairman of the firm's Pharmaceutical Litigation and Government Investigations Group, which includes over 150 lawyers engaged in government investigations and False Claims Act, product liability, consumer fraud, intellectual property, antitrust, commercial and administrative litigation for innovator life sciences companies. This practice is closely integrated with Covington’s FDA regulatory practice.

In addition to coordinating the firm’s pharmaceutical litigation practice, Lynch has represented GlaxoSmithKline in the Average Wholesale Price litigation for over a decade...
To view the full article, register now.